By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Caribou Biosciences 

2929 7th Street
Suite 120
Berkeley  California   94710  U.S.A.
Phone: 510-982-6030 Fax: n/a


SEARCH JOBS

Caribou Biosciences, Inc. is a leading company in CRISPR genome engineering located in Berkeley, CA. Caribou's tools and technologies provide transformative capabilities to therapeutic development, agricultural biotechnology, industrial biotechnology, and basic and applied biological research. The four-year-old company has developed a best-in-class CRISPR genome engineering technology platform and has a leading intellectual property position. The company has established strategic partnerships with DuPont (agriculture, industrial biotechnology) and Genus plc (agriculture) and has co-founded human therapeutics company Intellia Therapeutics (NASDAQ: NTLA.)


Key Statistics


Email:
Ownership: Private

Web Site: Caribou Biosciences
Employees:
Symbol: 
 









Company News
The Jackson Laboratory And Caribou Biosciences Announce CRISPR-Cas9 License Agreement 10/25/2016 10:37:28 AM
Caribou Biosciences’ President And CEO Rachel Haurwitz Named To Fortune’s 2016 "40 Under 40" List Of Most Influential Young People In Business 9/26/2016 8:48:38 AM
Caribou Biosciences Appoints Vonnie Estes As Group Leader, Agricultural And Industrial Biotechnology 8/30/2016 11:27:08 AM
Caribou Biosciences Develops New Method To Profile CRISPR-Cas9 Gene Editing Outcomes 8/18/2016 10:56:41 AM
31-Year-Old Rachel Haurwitz Helms Hot CRISPR-Based Biotech Firm Caribou Biosciences 6/22/2016 7:07:27 AM
Genus And Caribou Biosciences Announce Exclusive Collaboration For Leading CRISPR-Cas9 Gene Editing Technology In Livestock Species 5/18/2016 10:54:07 AM
Bay Area's Caribou Biosciences Reels in $30 Million 5/16/2016 6:02:19 AM
Caribou Biosciences' Co-Founder Dr. Jennifer Doudna And Chairman Of The Board Rodolphe Barrangou Selected For 2016 Canada Gairdner Awards 3/24/2016 7:55:29 AM
Caribou Biosciences And Integrated DNA Technologies Announce Non-Exclusive License Agreement For CRISPR-Cas9 Reagents 2/23/2016 10:00:21 AM
Caribou Biosciences’s New CRISPR Patent Isn’t About Gene Editing 2/18/2016 7:11:27 AM
12
//-->